Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic.

Breast Cancer Res Treat · 2021 · PMC7921279 · PMID 33651271

Europe PMC DOI

hedged sentence

0.3800

closest p · 7.6× alpha

0.3800

boldest claim

The sentences

did not reach statistical significancep = 0.38not close (p > 0.1)

Providers planning as short of duration of NET as possible tended to be from states with higher COVID-19 cases (average 74,451 cases) in May 2020 than those who planned minimum of 3 months (37,877 COVID-19 cases) or 6 months (28,636 COVID-19 cases) of NET, although this did not reach statistical significance ( p = 0.38).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.